rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
1997-1-23
|
pubmed:abstractText |
To determine whether the common side effect of ankle oedema with arteriolar vasodilators such as the calcium entry blocker (CEB) nifedipine and the potassium channel opener (PCO) diazoxide is the direct result of peripheral vasodilation or merely a consequence of renal sodium retention.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0263-6352
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1041-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8884561-Adult,
pubmed-meshheading:8884561-Cross-Over Studies,
pubmed-meshheading:8884561-Diazoxide,
pubmed-meshheading:8884561-Edema,
pubmed-meshheading:8884561-Female,
pubmed-meshheading:8884561-Humans,
pubmed-meshheading:8884561-Male,
pubmed-meshheading:8884561-Nifedipine,
pubmed-meshheading:8884561-Reproducibility of Results,
pubmed-meshheading:8884561-Sodium,
pubmed-meshheading:8884561-Vasodilator Agents
|
pubmed:year |
1996
|
pubmed:articleTitle |
Oedema formation with the vasodilators nifedipine and diazoxide: direct local effect or sodium retention?
|
pubmed:affiliation |
Department of Medicine, Sint Radboud Hospital, University of Nijmegen, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|